Anocca
Developer of drugs and immunotherapies intended to unlock the therapeutic potential of T-cell immunity. The company does precise analysis of T-cell biology that is required to deliver a range of thera...
Valuation
$0
Share Price
N/A
Total Raised
$210.2M
Last Round
N/A